Indian Pharmceutical Alliance (IPA) not in favor of Implementation of ‘Draft Pharma Policy’

Updated on November 7, 2017 in Pharma
1 on September 4, 2017

IPA says implementation of Draft Pharmaceutical Policy will complicate the Regulator’s functioning and lead to delays,the emphasis in improving manufacturing quality will increase cost of production and impact competitiveness of the Industry.

  • Liked by